Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

RNAi Topic Center

Featured Article

News
Treatment Provides Relief for Recurrent Acute Hepatic Porphyria Attacks
03/04/2022
Jolynn Tumolo
Patients with recurrent attacks of acute hepatic porphyria had fewer attacks and less health care dependency after treatment with a double-stranded small interfering RNA.
Patients with recurrent attacks of acute hepatic porphyria had fewer attacks and less health care dependency after treatment with a double-stranded small interfering RNA.
Patients with recurrent attacks...
03/04/2022
First Report Managed Care
News
Treatment Proves Highly Effective for Primary Hyperoxaluria Type 1
02/17/2022
Maria Asimopoulos
Eighteen months of follow-up data suggested lumasiran was highly effective in treating a patient with primary hyperoxaluria type 1, a rare genetic disease.
Eighteen months of follow-up data suggested lumasiran was highly effective in treating a patient with primary hyperoxaluria type 1, a rare genetic disease.
Eighteen months of follow-up...
02/17/2022
First Report Managed Care

Newsfeed

News
Treatment Provides Relief for Recurrent Acute Hepatic Porphyria Attacks
03/04/2022
Jolynn Tumolo
Patients with recurrent attacks of acute hepatic porphyria had fewer attacks and less health care dependency after treatment with a double-stranded small interfering RNA.
Patients with recurrent attacks of acute hepatic porphyria had fewer attacks and less health care dependency after treatment with a double-stranded small interfering RNA.
Patients with recurrent attacks...
03/04/2022
First Report Managed Care
News
Treatment Proves Highly Effective for Primary Hyperoxaluria Type 1
02/17/2022
Maria Asimopoulos
Eighteen months of follow-up data suggested lumasiran was highly effective in treating a patient with primary hyperoxaluria type 1, a rare genetic disease.
Eighteen months of follow-up data suggested lumasiran was highly effective in treating a patient with primary hyperoxaluria type 1, a rare genetic disease.
Eighteen months of follow-up...
02/17/2022
First Report Managed Care
News
HHS Unveils Comprehensive Healthcare Reforms to Boost Equity and Quality
09/13/2024
The US Department of Health and Human Services (HHS) has announced updates to Medicare payments and policies to improve healthcare accessibility, equity, and quality for millions of Americans, according to a press release by the HHS.
The US Department of Health and Human Services (HHS) has announced updates to Medicare payments and policies to improve healthcare accessibility, equity, and quality for millions of Americans, according to a press release by the HHS.
The US Department of Health and...
09/13/2024
First Report Managed Care
News
Challenges and Emerging Strategies in Overcoming Resistance in EGFR-Mutant NSCLC
09/10/2024
Despite promising early results, adding immunotherapy to standard chemotherapy does not significantly improve outcomes for patients with EGFR-mutant non-small cell lung cancer (NSCLC) who have progressed after initial targeted therapy,...
Despite promising early results, adding immunotherapy to standard chemotherapy does not significantly improve outcomes for patients with EGFR-mutant non-small cell lung cancer (NSCLC) who have progressed after initial targeted therapy,...
Despite promising early results,...
09/10/2024
First Report Managed Care
News
New 4F-PCC Proves Effective in Rapid Reversal of Anticoagulation for Urgent Surgery, Clinical Trial Finds
09/10/2024
An investigational 4-factor prothrombin complex concentrate (4F-PCC) is as effective and safe as an FDA-approved 4F-PCC for rapidly reversing vitamin K antagonist (VKA) anticoagulation in patients requiring urgent surgery, according to a...
An investigational 4-factor prothrombin complex concentrate (4F-PCC) is as effective and safe as an FDA-approved 4F-PCC for rapidly reversing vitamin K antagonist (VKA) anticoagulation in patients requiring urgent surgery, according to a...
An investigational 4-factor...
09/10/2024
First Report Managed Care
News
Obesity's Dual Role in Abdominal Aortic Aneurysm: Risk Factor and Protective Paradox
09/03/2024
Obesity, traditionally recognized as a significant public health threat due to its association with numerous metabolic, inflammatory, and psychosocial conditions, is now emerging as a complex factor in the development and progression of...
Obesity, traditionally recognized as a significant public health threat due to its association with numerous metabolic, inflammatory, and psychosocial conditions, is now emerging as a complex factor in the development and progression of...
Obesity, traditionally...
09/03/2024
First Report Managed Care
News
Stereotactic Magnetic Resonance (MR)-Guided Radiotherapy Shows Promise for Inoperable Upper Tract Urothelial Carcinoma
09/03/2024
Stereotactic MR-guided radiotherapy shows promise as an effective treatment for upper tract urothelial carcinoma (UTUC), particularly in patients who are not candidates for surgery, according to a case study presented in Frontiers in Oncology.
Stereotactic MR-guided radiotherapy shows promise as an effective treatment for upper tract urothelial carcinoma (UTUC), particularly in patients who are not candidates for surgery, according to a case study presented in Frontiers in Oncology.
Stereotactic MR-guided...
09/03/2024
First Report Managed Care
News
Targeting Expanded Follicular Regulatory T Cells Is a New Approach to Combat Follicular Lymphoma
08/26/2024
Follicular regulatory T cells (Tfr) are a potential target in treating follicular lymphoma (FL), the most common indolent B-cell lymphoma, according to study results published in Frontiers in Immunology.
Follicular regulatory T cells (Tfr) are a potential target in treating follicular lymphoma (FL), the most common indolent B-cell lymphoma, according to study results published in Frontiers in Immunology.
Follicular regulatory T cells...
08/26/2024
First Report Managed Care
News
Study Finds Gemcitabine-Docetaxel Combo Outperforms BCG in Treating High-Risk Bladder Cancer
08/23/2024
Gemcitabine and docetaxel therapy may be a viable alternative to bacillus Calmette-Guérin (BCG) for patients with high-risk non-muscle invasive bladder cancer (NMIBC), according to study results published in JAMA Network Open.
Gemcitabine and docetaxel therapy may be a viable alternative to bacillus Calmette-Guérin (BCG) for patients with high-risk non-muscle invasive bladder cancer (NMIBC), according to study results published in JAMA Network Open.
Gemcitabine and docetaxel...
08/23/2024
First Report Managed Care
News
Study Finds Low Vaccination Rates Among Pregnant Women With HIV
08/23/2024
Despite recommendations for routine prenatal care, pregnant women living with HIV (PLHIV) are receiving routine vaccinations at alarmingly low rates, according to a study published in JAMA Network Open.
Despite recommendations for routine prenatal care, pregnant women living with HIV (PLHIV) are receiving routine vaccinations at alarmingly low rates, according to a study published in JAMA Network Open.
Despite recommendations for...
08/23/2024
First Report Managed Care
News
Study Reveals Long-Term Care Insurance Reduces Hospital Costs and Improves Care
08/21/2024
Long-term care insurance can help reduce hospitalization costs and improve care for people with disabilities, according to a new study published in Frontiers in Public Health.
Long-term care insurance can help reduce hospitalization costs and improve care for people with disabilities, according to a new study published in Frontiers in Public Health.
Long-term care insurance can...
08/21/2024
First Report Managed Care
News
Dietary Patterns May Reshape Microbiota to Combat Obesity
08/19/2024
Dietary patterns that promote beneficial gut microbiota show promise in combating obesity and related metabolic diseases, according to recent research published in Frontiers in Nutrition.
Dietary patterns that promote beneficial gut microbiota show promise in combating obesity and related metabolic diseases, according to recent research published in Frontiers in Nutrition.
Dietary patterns that promote...
08/19/2024
First Report Managed Care

Advertisement

Advertisement

What's New?

News
Treatment Provides Relief for Recurrent Acute Hepatic Porphyria Attacks
03/04/2022
Jolynn Tumolo
Patients with recurrent attacks of acute hepatic porphyria had fewer attacks and less health care dependency after treatment with a double-stranded small interfering RNA.
Patients with recurrent attacks of acute hepatic porphyria had fewer attacks and less health care dependency after treatment with a double-stranded small interfering RNA.
Patients with recurrent attacks...
03/04/2022
First Report Managed Care
News
Treatment Proves Highly Effective for Primary Hyperoxaluria Type 1
02/17/2022
Maria Asimopoulos
Eighteen months of follow-up data suggested lumasiran was highly effective in treating a patient with primary hyperoxaluria type 1, a rare genetic disease.
Eighteen months of follow-up data suggested lumasiran was highly effective in treating a patient with primary hyperoxaluria type 1, a rare genetic disease.
Eighteen months of follow-up...
02/17/2022
First Report Managed Care

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement